{
  "ticker": "AVXL",
  "success": true,
  "price": {
    "current": 4.91,
    "currency": "USD",
    "day_high": 4.985,
    "day_low": 4.78,
    "52_week_high": 13.99,
    "52_week_low": 2.86
  },
  "market_cap": {
    "value": 438699168.0,
    "currency": "USD"
  },
  "shares_outstanding": 89348107.0,
  "volume": {
    "last": 728532,
    "average_30d": 1588139
  },
  "valuation": {
    "pe_ratio": null,
    "forward_pe": 3.8661416,
    "price_to_book": 4.484018
  },
  "company_info": {
    "name": "Anavex Life Sciences Corp.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 103815000.0,
    "total_liabilities": 8946000.0,
    "stockholders_equity": 94869000.0,
    "cash": 102577000.0,
    "marketable_securities": null,
    "total_liquidity": 102577000.0,
    "total_debt": null,
    "long_term_debt": null,
    "current_debt": null,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:30:12.719696",
    "url": "https://finance.yahoo.com/quote/AVXL",
    "data_hash": "50b043ac44c6aa9f"
  }
}